Clinical trial
The Ribavirin Pregnancy Registry
NCT00114712 · Syneos Health, Other · Terminated
Key facts
| NCT number | NCT00114712 |
|---|---|
| Title | The Ribavirin Pregnancy Registry |
| Official title | The Ribavirin Pregnancy Registry |
| Acronym | RPR |
| Lead sponsor | Syneos Health, Other |
| Collaborators | Aurobindo Pharma Ltd Industry Sandoz Merck Sharp & Dohme LLC Teva Pharmaceuticals USA Zydus Pharmaceuticals USA, Inc. |
| Status | Terminated |
| Study type | Observational [Patient Registry] |
| Conditions | Birth Defects, Pregnancy Complications, Hepatitis C |
| Enrollment | 477 |
| Start date | Jan 1, 2004 |
| Primary completion | Nov 2, 2020 |
| Completion | Nov 2, 2020 |
| First posted | Jun 17, 2005 |
| Last update posted | Dec 14, 2020 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: